DNA-methylation
clocks
inform
not
only
about
chronological
but
also
biological
age,
which
brings
a
high
resolution
and
precise
understanding
of
age-related
pathology
physiology.
Attempts
based
on
transcriptomic
epigenetic
approaches
arise
as
integrative
biomarkers
linking
the
quantification
stress
response
with
given
fitness
trait
may
help
to
identify
age
markers,
considered
welfare
indicators.
In
gilthead
sea
bream,
targeted
gene
expression
analyses
in
white
skeletal
muscle
proved
sirt1
reliable
marker
age-mediated
changes
energy
metabolism.
To
complete
list
auditing
biomarkers,
wide-analyses
one-
three-year
old
fish
were
combined.
After
discriminant
analysis,
668
differentially
expressed
transcripts
matched
those
containing
methylated
(DM)
regions
(14,366),
172
overlapping.
Through
enrichment
selection,
two
sets
genes
retained:
33
showing
an
opposite
trend
for
expression,
57
down-regulated
hypo-methylated.
The
first
set
displayed
apparently
more
reproducible
pattern
10
multifunctional
DM
CpG
regulatory
(sirt1,
smad1,
ramp1,
psmd2
–
up-regulated;
col5a1,
calcrl,
bmp1,
thrb,
spred2,
atp1a2
down-regulated)
deemed
candidate
markers
improved
bream.
Ageing Research Reviews,
Journal Year:
2024,
Volume and Issue:
95, P. 102204 - 102204
Published: Jan. 23, 2024
The
pursuit
for
the
fountain
of
youth
has
long
been
a
fascination
amongst
scientists
and
humanity.
Ageing
is
broadly
characterized
by
cellular
decline
with
increased
susceptibility
to
age-related
diseases,
being
intimately
associated
epigenetic
modifications.
Recently,
reprogramming-induced
rejuvenation
strategies
have
begun
greatly
alter
longevity
research
not
only
tackle
defects
but
also
possibly
reverse
ageing
process.
Hence,
in
this
review,
we
highlight
major
changes
during
state-of-art
current
emerging
reprogramming
leveraging
on
transcription
factors.
Notably,
partial
enables
resetting
clock
without
erasing
identity.
Promising
chemical-based
harnessing
small
molecules,
including
DNA
methyltransferase
histone
deacetylase
inhibitors
are
discussed.
Moreover,
parallel
interventions,
foundations
clocks
accurate
assessment
evaluation
approaches
briefly
presented.
Going
further,
such
scientific
breakthroughs,
witnessing
rise
biotech
industry
aiming
extend
health
span
ideally
achieve
human
one
day.
In
context,
overview
main
scenarios
proposed
future
socio-economic
ethical
challenges
an
field.
Ultimately,
review
aims
inspire
interventions
that
promote
healthy
all.
Cells,
Journal Year:
2024,
Volume and Issue:
13(5), P. 390 - 390
Published: Feb. 24, 2024
Aging
populations
worldwide
are
placing
age-related
diseases
at
the
forefront
of
research
agenda.
The
therapeutic
potential
natural
substances,
especially
propolis
and
its
components,
has
led
to
these
products
being
promising
agents
for
alleviating
several
cellular
molecular-level
changes
associated
with
diseases.
With
this
in
mind,
scientists
have
introduced
a
contextual
framework
guide
future
aging
research,
called
hallmarks
aging.
This
encompasses
various
mechanisms
including
genomic
instability,
epigenetic
changes,
mitochondrial
dysfunction,
inflammation,
impaired
nutrient
sensing,
altered
intercellular
communication.
Propolis,
rich
array
bioactive
compounds,
functions
as
potent
functional
food,
modulating
metabolism,
gut
microbiota,
immune
response,
offering
significant
health
benefits.
Studies
emphasize
propolis'
properties,
such
antitumor,
cardioprotective,
neuroprotective
effects,
well
ability
mitigate
oxidative
stress,
DNA
damage,
pathogenic
bacteria
growth.
article
underscores
current
scientific
evidence
supporting
role
controlling
molecular
characteristics
linked
hallmarks,
hypothesizing
geroscience
research.
aim
is
discover
novel
strategies
improve
quality
life
older
individuals,
addressing
existing
deficits
perspectives
area.
Journal of Cellular Immunology,
Journal Year:
2023,
Volume and Issue:
5(4), P. 127 - 140
Published: Nov. 29, 2023
Background:
Cancer
remains
a
leading
cause
of
mortality
with
modest
declines,
highlighting
the
need
for
more
efficacious
prevention
strategies
like
early
immunological
intervention
against
premalignant
disease.
Main
body
abstract:
Oncogenic
viruses
demonstrate
prophylactic
vaccines
can
successfully
reduce
malignancy
by
blocking
precipitating
infections.
However,
most
cancers
lack
viral
etiology,
requiring
novel
approaches
targeting
sporadic
precancerous
states
to
enable
immunoprevention.
Preneoplastic
tissues
exhibit
biological
changes
making
them
appealing
targets
stimulating
immune
surveillance
before
additional
mutations
unconstrained
proliferation.
High-risk
precancers
also
provide
sources
dysregulated
self-antigens.
Yet
challenges
exist
in
lesion
identification,
overcoming
tolerance,
and
avoiding
inflammation
potentially
worsening
progression.
Multidisciplinary
insights
into
precancer
immunology,
predictive
biomarkers,
antigen
discovery,
combinatorial
vaccination
are
illuminating
rational
vaccine
design.
Despite
obstacles,
immunization
dysplastic
holds
disruptive
potential
if
key
steps
advance
this
approach.
Elucidating
preneoplasia
immunobiology
progression
risk
modeling
will
be
critical
guide
productive
while
mitigating
immunotherapy
hazards.
Thoughtful
translation
could
eventually
shift
paradigms
priming
immunosurveillance
peak
vulnerability
lesions.
Short
Conclusion:
Advancements
may
profoundly
expand
horizons.
Cautious
intercept
toward
widely
disseminated
malignancies.
This
warrants
methodical
efforts
unravel
promise
thwarting
lethal
they
start.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 19, 2024
In
this
narrative
review,
we
sought
to
provide
a
comprehensive
overview
of
the
mechanisms
underlying
cutaneous
senescence,
framed
by
twelve
traditional
hallmarks
aging.
These
include
genomic
instability,
telomere
attrition,
epigenetic
alterations,
loss
proteostasis,
impaired
macroautophagy,
deregulated
nutrient
sensing,
mitochondrial
dysfunction,
cellular
stem
cell
exhaustion,
altered
intercellular
communication,
chronic
inflammation,
and
dysbiosis.
We
also
examined
how
topical
interventions
targeting
these
can
be
integrated
with
conventional
aesthetic
medicine
techniques
enhance
skin
rejuvenation.
The
potential
combining
targeted
therapies
against
aging
minimally
invasive
procedures
represents
significant
advancement
in
medicine,
offering
personalized
effective
strategies
combat
reviewed
evidence
paves
way
for
future
advancements
underscores
transformative
integrating
scientifically
validated
into
practices.
Journal of the European Academy of Dermatology and Venereology,
Journal Year:
2024,
Volume and Issue:
38(S4), P. 5 - 14
Published: June 17, 2024
Abstract
Senescence
and
epigenetic
alterations
are
two
important
hallmarks
of
cellular
aging.
During
aging,
cells
subjected
to
stress
undergo
many
cycles
damage
repair
before
finally
entering
either
apoptosis
or
senescence,
a
permanent
state
cell
cycle
arrest.
The
first
biomarkers
senescence
be
identified
were
increased
ß‐galactosidase
activity
induction
p16
INK4a
.
Another
feature
senescent
is
the
senescence‐associated
secretory
phenotype
(SASP),
complex
secretome
containing
more
than
80
pro‐inflammatory
factors
including
metalloproteinases,
growth
factors,
chemokines
cytokines.
regulated
through
dynamic
process
involving
self‐amplifying
autocrine
feedback
loop
activation
immune
system.
Senescent
play
positive
negative
roles
depending
on
composition
their
SASP
may
participate
in
various
processes
wound
healing
tumour
suppression,
as
well
regeneration,
embryogenesis,
tumorigenesis,
inflammation
also
biomarker
age,
biological
aging
age‐related
diseases.
Recent
advances
anti‐age
research
have
shown
that
can
now
prevented
delayed
by
clearing
mitigating
effects
which
achieved
healthy
lifestyle
(exercise
diet),
senolytics
senomorphics,
respectively.
An
alternative
tissue
rejuvenation,
stimulating
aged
stem
reprogramming
deprogrammed
cells.
These
non‐clinical
findings
will
open
up
new
avenues
clinical
into
development
treatments
capable
preventing
treating
pathologies
humans.
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(9), P. 931 - 931
Published: Aug. 31, 2024
Aging
is
a
fundamental
biological
process
characterized
by
progressive
decline
in
physiological
functions
and
an
increased
susceptibility
to
diseases.
Understanding
aging
at
the
molecular
level
crucial
for
developing
interventions
that
could
delay
or
reverse
its
effects.
This
review
explores
integration
of
machine
learning
(ML)
with
multi-omics
technologies-including
genomics,
transcriptomics,
epigenomics,
proteomics,
metabolomics-in
studying
hallmarks
develop
personalized
medicine
interventions.
These
include
genomic
instability,
telomere
attrition,
epigenetic
alterations,
loss
proteostasis,
disabled
macroautophagy,
deregulated
nutrient
sensing,
mitochondrial
dysfunction,
cellular
senescence,
stem
cell
exhaustion,
altered
intercellular
communication,
chronic
inflammation,
dysbiosis.
Using
ML
analyze
big
complex
datasets
helps
uncover
detailed
interactions
pathways
play
role
aging.
The
advances
can
facilitate
discovery
biomarkers
therapeutic
targets,
offering
insights
into
anti-aging
strategies.
With
these
developments,
future
points
toward
better
understanding
process,
aiming
ultimately
promote
healthy
extend
life
expectancy.
Frontiers in Aging,
Journal Year:
2025,
Volume and Issue:
6
Published: Jan. 24, 2025
Aging
research
has
rapidly
advanced
from
fundamental
discoveries
at
the
molecular
and
cellular
levels
to
promising
clinical
applications.
This
review
discusses
critical
translational
insights
that
bridge
gap
between
bench
bedside
applications,
highlighting
key
in
mechanisms
of
aging,
biomarkers,
therapeutic
interventions.
It
underscores
importance
interdisciplinary
approaches
collaboration
among
scientists,
clinicians,
policymakers
address
complexities
aging
improve
health
span.
American Journal of Clinical Oncology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 28, 2025
Objectives:
Sarcomas
are
complex
mesenchymal
malignancies
whose
molecular
characteristics
can
significantly
influence
treatment
strategies.
This
study
aimed
to
investigate
the
relationship
between
tumor
purity,
mutation
load,
and
clinical
across
sarcoma
subtypes,
focusing
on
potential
implications
for
therapeutic
stratification.
Methods:
analyzed
of
7494
cases
from
Soft
Tissue
Bone
Sarcoma
(MSK,
Nat
Commun
2022)
data
set
using
available
case
analysis.
Correlations
age,
sex
were
nonparametric
methods,
with
subtype-specific
analyses
conducted
Kruskal-Wallis
tests
Bonferroni-corrected
post
hoc
comparisons.
A
comprehensive
analysis
patterns
was
performed
microsatellite
instability
(MSI)
status.
Results:
Significant
correlations
load
purity
(ρ=0.320,
P
<0.001)
identified,
marked
heterogeneity
subtypes.
Tumor
ranged
20.0%
in
brain
sarcomas
78.5%
dermatofibrosarcoma
protuberans.
Age-related
changes
observed
(ρ=0.711,
=0.006)
skin
(ρ=0.450,
=0.006),
suggesting
distinct
evolutionary
patterns.
subset
hypermutated,
stable
(0.15%)
loads
exceeding
100
mutations/mb
alternative
mechanisms
genomic
instability.
MSI-high
status
rare
(0.24%)
but
associated
higher
(median:
25.84
vs.
2.42,
<0.001),
particularly
uterine
(0.7%
prevalence).
Conclusions:
The
identification
subtypes
challenge
existing
morphology-based
classification
systems
may
hold
These
findings
help
inform
future
immunotherapeutic
molecular-guided
approaches
patients,
elderly
patients
or
females
sarcomas.
Epigenomes,
Journal Year:
2025,
Volume and Issue:
9(1), P. 5 - 5
Published: Feb. 5, 2025
Genomic
and
epigenomic
instability
are
defining
features
of
cancer,
driving
tumor
progression,
heterogeneity,
therapeutic
resistance.
Central
to
this
process
epigenetic
echoes,
persistent
dynamic
modifications
in
DNA
methylation,
histone
modifications,
non-coding
RNA
regulation,
chromatin
remodeling
that
mirror
underlying
genomic
chaos
actively
influence
cancer
cell
behavior.
This
review
delves
into
the
complex
relationship
between
these
illustrating
how
they
collectively
shape
genome,
affect
repair
mechanisms,
contribute
evolution.
However,
dynamic,
context-dependent
nature
changes
presents
scientific
ethical
challenges,
particularly
concerning
privacy
clinical
applicability.
Focusing
on
lung
we
examine
specific
patterns
function
as
biomarkers
for
distinguishing
subtypes
monitoring
disease
progression
relapse.